Works matching DE "DRUG price laws"

Results: 77

Does drug price-regulation affect healthcare expenditures?

Published in:

2017

By:

Ben-Aharon, Omer;
Shavit, Oren;
Magnezi, Racheli

Publication type:

journal article

Lead me not into temptation: drug price regulation and dispensing physicians in Switzerland.

Published in:

European Journal of Health Economics, 2014, v. 15, n. 7, p. 697, doi. 10.1007/s10198-013-0515-y

By:

Rischatsch, Maurus

Publication type:

Article

80% of Medicines not covered by Price control order.

Published in:: IDA Times, 2014, v. 10, n. 1, p. 16
Publication type:: Article

REVERSE PAYMENTS IN THE PHARMACEUTICAL INDUSTRY: FINDING THE RIGHT PRESCRIPTION.

Published in:

Southern Law Journal, 2012, v. 22, n. 1, p. 61

By:

Royalty, Kent W;
Oliva, Suzanne;
Fix, William A.

Publication type:

Article

Product Hopping.

Published in:

Journal of Commercial Biotechnology, 2017, v. 23, n. 2, p. 52, doi. 10.5912/jcb795

By:

Carrier, Michael A.

Publication type:

Article

Taxpayers' Share of US Prescription Drug and Insulin Costs: a Cross-Sectional Study.

Published in:

JGIM: Journal of General Internal Medicine, 2025, v. 40, n. 6, p. 1325, doi. 10.1007/s11606-024-09032-x

By:

Schrier, Elizabeth;
Himmelstein, David U.;
Gaffney, Adam;
McCormick, Danny;
Woolhandler, Steffie

Publication type:

Article

Adverse Reaction Without a Remedy.

Published in:

Alabama Lawyer, 2012, v. 73, n. 1, p. 59

By:

Casey, Steven F.;
Lester, David A.

Publication type:

Article

Let cool heads prevail.

Published in:

Australian Journal of Pharmacy, 2009, v. 90, n. 1069, p. 21

By:

Sclavos, Kos

Publication type:

Article

Straight talk with... Mark Sculpher.

Published in:: Nature Medicine, 2012, v. 18, n. 9, p. 1315, doi. 10.1038/nm0912-1315
Publication type:: Article

SALUD Y ALIMENTACIÓN.

Published in:: Actualidad Jurídica (1578-956X), 2014, n. 37, p. 296
Publication type:: Article

Off-patent drugs at brand-name prices: a puzzle for policymakers.

Published in:

Journal of Law & the Biosciences, 2016, v. 3, n. 1, p. 238, doi. 10.1093/jlb/lsw008

By:

Tallapragada, Naren P.

Publication type:

Article

New California Law Limits Drug Manufacturer Co-Pay Cards and Other Discounts in California.

Published in:

Journal of Health Care Compliance, 2017, v. 19, n. 6, p. 55

By:

TRILLING, HELEN;
ANDONOVA, ELIZA;
MCDONALD, LAURA;
WISOR, RON;
FURLOW, ANDREW

Publication type:

Article

USING REVERSE PAYMENT AGREEMENTS AS AN EFFECTIVE WAY TO MAINTAIN A PATENT MONOPOLY IN THE PHARMACEUTICAL INDUSTRY.

Published in:

American University Journal of Gender, Social Policy & the Law, 2013, v. 21, n. 4, p. 919

By:

FORD, BRIANNA

Publication type:

Article

Market spiral pricing of cancer drugs.

Published in:

Cancer (0008543X), 2013, v. 119, n. 22, p. 3900, doi. 10.1002/cncr.28321

By:

Light, Donald W.;
Kantarjian, Hagop

Publication type:

Article

A licence to lower costs.

Published in:: Chemistry & Industry, 2012, v. 76, n. 10, p. 45, doi. 10.1002/cind.7610_15.x
Publication type:: Article

Pricing plan won't hurt innovation.

Published in:

Chemistry & Industry, 2008, n. 23, p. 7

By:

Dorey, Emma

Publication type:

Article

PRICING DRUGS FAIRLY.

Published in:

William & Mary Law Review, 2021, v. 62, n. 3, p. 929

By:

PERSAD, GOVIND

Publication type:

Article

Sales Growth of New Pharmaceuticals Across the Globe: The Role of Regulatory Regimes.

Published in:

Marketing Science, 2009, v. 28, n. 4, p. 690, doi. 10.1287/mksc.1080.0440

By:

Stremersch, Stefan;
Lemmens, Aurélie

Publication type:

Article

Pharmaceutical policy regarding generic drugs in Belgium.

Published in:

2005

By:

Simoens, Steven;
De Bruyn, Kristien;
Bogaert, Marc;
Laekeman, Gert

Publication type:

journal article

Successful patent challenges hinder innovation in pharmaceutical industry.

Published in:

Ocular Surgery News, 2009, v. 27, n. 23, p. 45

By:

Hasson, Matt

Publication type:

Article

Business Update.

Published in:: Applied Clinical Trials, 2004, v. 13, n. 5, p. 64
Publication type:: Article

Coping with the Cost of Prescription Benefits.

Published in:

Applied Clinical Trials, 2002, v. 11, n. 9, p. 20

By:

Wechsler, Jill

Publication type:

Article

HATCH-WAXMAN PATENT LITIGATION AND INTER PARTES REVIEW: A NEW SORT OF COMPETITION.

Published in:

Alabama Law Review, 2017, v. 69, n. 1, p. 59

By:

Sturiale, Jennifer E.

Publication type:

Article

I Get By with a Little Help from My 750-Dollar-Per-Tablet Friends: A Model Act for States to Prevent Dramatic Pharmaceutical Price Increases.

Published in:

Minnesota Law Review, 2018, v. 102, n. 6, p. 2497

By:

Walsdorf, Alexander

Publication type:

Article

Dangerous Times: The FDA's Role in Information Production, Past and Future.

Published in:

Minnesota Law Review, 2018, v. 102, n. 6, p. 2357

By:

Kapczynski, Amy

Publication type:

Article

What Makes Ensuring Access to Affordable Prescription Drugs the Hardest Problem in Health Policy?

Published in:

Minnesota Law Review, 2018, v. 102, n. 6, p. 2273

By:

Mello, Michelle M.

Publication type:

Article

Changing Course to Navigate the Patent Safe Harbor Post-Momenta.

Published in:

Minnesota Law Review, 2014, v. 98, n. 4, p. 1565

By:

Wessels, Emily M.

Publication type:

Article

PHARMACEUTICAL PRICE CONTROLS AND ENTRY STRATEGIES.

Published in:

Review of Economics & Statistics, 2007, v. 89, n. 1, p. 88, doi. 10.1162/rest.89.1.88

By:

Kyle, Margaret K.

Publication type:

Article

Price controls seen as key to Europe's drug innovation lag.

Published in:

Nature Reviews Drug Discovery, 2007, v. 6, n. 4, p. 257, doi. 10.1038/nrd2293

By:

Mitchell, Peter

Publication type:

Article

Can the pharmaceutical industry reduce attrition rates?

Published in:

2004

By:

Kola, Ismail;
Landis, John

Publication type:

review

Ending Reverse-Payment Immunity: A Proposed Framework for Antitrust Scrutiny Under California's Cartwright Act.

Published in:

McGeorge Law Review, 2014, v. 46, n. 3, p. 659

By:

Serrao, Anthony

Publication type:

Article

Germany caps drug prices.

Published in:

Nature Biotechnology, 2011, v. 29, n. 2, p. 96, doi. 10.1038/nbt0211-96a

By:

Mitchell, Peter

Publication type:

Article

The History and Political Economy of the Hatch-Waxman Amendments.

Published in:

Seton Hall Law Review, 2019, v. 49, n. 1, p. 53

By:

Lietzan, Erika

Publication type:

Article

THE HATCH-WAXMAN ACT'S SIDE EFFECTS: PRECAUTIONS FOR BIOSIMILARS.

Published in:

Loyola of Los Angeles Law Review, 2014, v. 47, n. 4, p. 917

By:

Laakmann, Anna B.

Publication type:

Article

Ailing pharma.

Published in:: 2014
Publication type:: Opinion

Bid to limit prices on drugs using `public' discoveries.

Published in:

Nature, 1998, v. 393, n. 6683, p. 297, doi. 10.1038/30570

By:

Wadman, Meredith

Publication type:

Article

India moves gently to liberalize drug industry.

Published in:

Nature, 1994, v. 371, n. 6492, p. 8, doi. 10.1038/371008b0

By:

Jayaraman, K.S.

Publication type:

Article

The New York Pharmaceutical Cost Transparency Act.

Published in:

Brooklyn Law Review, 2016, v. 82, n. 1, p. 315

By:

Curran, John G.

Publication type:

Article

A DRUG'S WORTH: WHY FEDERAL LAW MAKES IT HARD TO PAY FOR PHARMACEUTICAL PERFORMANCE.

Published in:

Boston University Law Review, 2018, v. 98, n. 1, p. 303

By:

Staley, Lee B.

Publication type:

Article

SAME PILL, DIFFERENT PRICE: THE CASE FOR POLICY REFORM IN THE UNITED STATES BASED ON PHARMACEUTICALS' ACCESS STRATEGIES IN INTERNATIONAL MARKETS.

Published in:

California Western International Law Journal, 2019, v. 49, n. 2, p. 391

By:

Daveler, Timothy

Publication type:

Article

Do Firms Purposefully Change Capital Structure? Evidence from an Investment-Opportunity Shock to Drug Firms.

Published in:

Journal of Financial & Quantitative Analysis, 2021, v. 56, n. 3, p. 915, doi. 10.1017/S0022109020000095

By:

Giambona, Erasmo;
Golec, Joseph;
Lopez-de-Silanes, Florencio

Publication type:

Article

TRADEMARKS, TRADE DRESS, AND THE PATIENT COSTS OF PHARMACEUTICAL BRANDING.

Published in:

Journal of Intellectual Property & Entertainment Law, 2021, v. 11, n. 2, p. 132

By:

HALABI, SAM F.

Publication type:

Article

National pharmacare, reference-based pricing, and drug R&D: A critique of the National Forum on....

Published in:

Canadian Public Policy, 1999, v. 25, n. 1, p. 1, doi. 10.2307/3551399

By:

Lindsey, Robin;
West, Douglas S.

Publication type:

Article

Journal Watch.

Published in:: Pharmaceutical Medicine, 2011, v. 25, n. 4, p. 269, doi. 10.1007/BF03256869
Publication type:: Article

News in brief.

Published in:

Indian Pediatrics, 2015, v. 52, n. 8, p. 721, doi. 10.1007/s13312-015-0707-x

By:

Passi, Gouri

Publication type:

Article

Germany moves to lower drug prices.

Published in:

Canadian Medical Association Journal (CMAJ), 2011, v. 183, n. 2, p. E77, doi. 10.1503/cmaj.109-3759

By:

Kupferschmidt, Kai

Publication type:

Article

EL SISTEMA DE PRECIOS DE REFERENCIA: QUINCE AÑOS DE EXPERIENCIA.

Published in:

Actualidad Jurídica (1578-956X), 2012, n. 33, p. 35

By:

PAZ-ARES, TERESA;
COCINA, BEATRIZ

Publication type:

Article

SALUD Y ALIMENTACIÓN.

Published in:

Actualidad Jurídica (1578-956X), 2012, n. 32, p. 236

By:

Guerrero Trevijano, Susana;
Solís García, José;
Montoro Moreno, Antonio Javier;
Balmaseda Serrat-Valera, Constanza;
Ferreira Malaquias, Pedro;
Rebêlo, Maria Goreti;
Frias, Helder;
Almeida Carvalho, Mafalda;
Geraldes, Lara;
Torres Ereio, Joana

Publication type:

Article

ANÁLISIS LEGAL DE DETERMINADAS MEDIDAS «ANTICRISIS» ADOPTADAS POR LAS COMUNIDADES AUTÓNOMAS PARA REDUCIR EL GASTO FARMACÉUTICO.

Published in:

Actualidad Jurídica (1578-956X), 2011, n. 30, p. 96

By:

Guerrero Trevijano, Susana

Publication type:

Article

SALUD Y ALIMENTACIÓN.

Published in:: Actualidad Jurídica (1578-956X), 2010, n. 26, p. 181
Publication type:: Article